It’s Time to Take Things Personally: Individualized Care in Diabetes-It’s Time to Take Things Personally: Individualized Care in Diabetes

Video Transcription

Video Summary

The first summary discusses precision medicine in the context of monogenic diabetes. Dr. Rochelle Naylor explains the importance of precision diagnosis to accurately classify diabetes type and inform treatment strategies. Biomarkers and genetic testing can aid in identifying monogenic diabetes and guide treatment decisions. Naylor highlights the cost-effectiveness of precision medicine for monogenic diabetes and its potential to improve patient outcomes.<br /><br />The second summary focuses on prediction models for all-cause mortality in patients with type 2 diabetes. The speaker discusses well-established models and efforts to enhance their performance. A study using metabolomic markers found six metabolites significantly associated with all-cause mortality in type 2 diabetes patients. Three of these metabolites were validated in an independent sample, and their addition to the prediction models improved their performance. The speaker also mentions the relevance of metabolomic markers in studying novel pathogenic pathways and acknowledges the need for further research to validate prediction models and explore subgroups within the population of patients with type 2 diabetes.<br /><br />No specific credits were mentioned in the summaries.

Keywords

precision medicine

monogenic diabetes

diabetes type

treatment strategies

biomarkers

genetic testing

cost-effectiveness

patient outcomes

prediction models

all-cause mortality

type 2 diabetes

metabolomic markers


EndoCareers \| Contact Us \| Privacy Policy \| Terms of Use	CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.	2055 L Street NW, Suite 600 \| Washington, DC 20036 202.971.3636 \| 888.363.6274